Journal article
Phase II study of pegylated liposomal doxorubicin HCI (caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer
Authors
Leighl NB; Goss GD; Lopez P; Burkes RL; Dancey JE; Rahim YH; Rudinskas LC; Rodgers A; Pond GR; Shepherd FA
Journal
Lung Cancer, Vol. 41, ,
Publisher
Elsevier
Publication Date
August 1, 2003
DOI
10.1016/s0169-5002(03)92523-2
ISSN
0169-5002